GAMMA Investing’s Treace Medical Concepts TMCI Stock Holding History

GAMMA Investing’s Portfolio TMCI Stock Details TMCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$186	Buy	+42	New	+$188	﹤0.01%	4282
2026 Q2	–	Sell	-289	Closed	-$387	–	4230
2026 Q1	$387	Buy	+289	New	+$576	﹤0.01%	3988
2025 Q4	–	Sell	-453	Closed	-$3.04K	–	4137
2025 Q3	$3.04K	Sell	453 -3	-0.7%	-$20	﹤0.01%	3336
2025 Q2	$2.68K	Sell	456 -776	-63%	-$5.06K	﹤0.01%	3320
2025 Q1	$10.3K	Buy	1,232 +1,132	+1,132%	+$10.2K	﹤0.01%	2728
2024 Q4	$744	Buy	+100	New	+$669	﹤0.01%	3499
2024 Q3	–	Sell	-4,639	Closed	-$30.8K	–	3650
2024 Q2	$30.8K	Buy	4,639 +4,508	+3,441%	+$36.4K	﹤0.01%	1560
2024 Q1	$1.71K	Buy	131 +75	+134%	+$1K	﹤0.01%	2790
2023 Q4	$755	Buy	+56	New	+$566	﹤0.01%	2871

Other funds holding TMCI

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

MAM

Marquette Asset Management Minneapolis, Minnesota $766M AUM 16.04% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

GAMMA Investing's TMCI Position: Q3 2026 in Review

GAMMA Investing opened a new position in Treace Medical Concepts (TMCI) in Q3 2026: 42 shares worth $186. The stake represents ﹤0.01% of the portfolio and ranks #4282 among its holdings. This is a return to the name: GAMMA Investing previously reported a position in TMCI as recently as Q1 2026.

GAMMA Investing first reported a position in TMCI in Q4 2023 and has held it in 9 quarters since. The position peaked at $30.8K in Q2 2024. 4 funds tracked by Wall St. Rank hold TMCI as of Q3 2026.

GAMMA Investing held 42 shares of Treace Medical Concepts worth $186 as of Q3 2026.
Treace Medical Concepts was a new GAMMA Investing position in Q3 2026.
Treace Medical Concepts made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #4282 holding.
GAMMA Investing first reported a position in Treace Medical Concepts in Q4 2023 and has held it in 9 quarters since.
GAMMA Investing's Treace Medical Concepts position peaked at $30.8K in Q2 2024.
4 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.